|
⚲
|
| KKR Americas XII Indigo Blocker Parent LP | |
|---|---|
| Firm |
Kohlberg Kravis Roberts & Co LP
✚
|
| Fund # | 805-6065923838 |
| CIK # | |
| Sale | |
| Fund | Private Equity Fund |
| Phone | |
| Address | |
| Source | [IAPD] |
| Fund AUM and Sold ($M) |
|---|
| Fund Details | |
|---|---|
| Director | KKR Associates Americas XII LP |
| Custodian | JP Morgan Chase Bank NA |
| Auditor | Deloitte & Touche LLP |
| Marketer | |
| Broker | |
| Jurisdiction |
| Comparable Firms | State | AUM ($B) |
|---|---|---|
|
JE Fund I, a series of Unpopular VC, LP
✚
|
0.0 | |
|
JE Fund II, a series of Unpopular VC, LP
✚
|
0.0 | |
|
Jeifetz Martha V.
✚
|
0.0 | |
|
JEM Ventures Series 1
✚
|
0.0 | |
|
JEM Ventures Series 2
✚
|
0.0 | |
|
Jengu Therapeutics, Inc.
✚
|
0.0 | |
|
Jenkins David H
✚
|
0.0 | |
|
Jenkin Thomas M
✚
|
0.0 | |
|
Jennings Kevin
✚
|
0.0 | |
|
Jedar Capital Cohort 16, a Series of Assure Labs 2022, LLC
✚
|
0.0 |